Patent hypocrisies of US

American business lobbies are spreading falsehoods about India’s patent policies—and glossing over their double standards

Drug affordability test

Natco’s bid for a compulsory licence to manufacture a Bayer anti-cancer drug is a test of the law’s ‘reasonable price’ …

Mark Lynas and the demeaning of science

He’s fuzzy on facts and low on science, but the campaigner gets big media support

A pre-emptive strike against Monsanto

American organic farmers are trying to ensure the biotech giant cannot sue them

Dangers ahead at WTO

The trade facilitation agreement paves the way for fresh pressures on developing countries such as tariff cuts on industrial products

A lethal secrecy in trade deals

Why do democratic governments hide trade negotiations that have dire consequences for public services?

Pursuing a nationalist IPR policy

India has enough laws to protect its intellectual property rights. It is the implementation that is wanting

The pirates come ashore

German Pirate Party’s strong showing in the May elections is a sign that anti-IPR movements resonate with the people

Bringing Google to book

Google’s digital library project went too far, creating a monopoly over the heritage of books

The curious case of Ebola patents

The US government appears to have a cure and (almost) a vaccine for the deadly disease

Biosafety issues get a push

Experts to study socio-economic aspects of GMO release

Industry paid for IP seminars to train judges

Microsoft and Indian Music Industry funded FICCI to hold roundtable for Maharashtra judiciary; judges handling piracy cases special invitees

Whose homeland security?

Nuclear fault lines run deep

Secrecy, fettered regulator are a worry as India plans nuclear expansion

Patent issues delaying Ebola cure

Canada's exclusive licensing rights of its Ebola patent to a US firm are holding up global development of a vaccine

ACTA fury goes viral

Europe is on the boil over an anti-piracy bill that will curb Internet freedom but its impact on trade in generic medicines is not on the radar

The idea of corruption

Prime Minister’s Logic

Obituary: Ashish Bose, a man who counted

India’s foremost demographer had a lively interest in a host of societal issues, specially the state of the aam aadmi

Big pharma’s dirty tricks

Drug giants from GSK, Abbott and Pfizer to Bayer have been fined for serious malpractices. They should be under close watch in India

Disclosure-shy industry

Pharma and biotech firms are lobbying hard to block disclosure of origin of genetic material used in inventions, but they also raise thorny issues

New endosulfan ploy

Industry is sidestepping issues by pitching the proposed UN ban on endosulfan as the battle between generics and patented pesticides

Predatory EU pacts

EU is pushing India and Canada to sign free trade agreements that will hurt their generic drugs—and the outrage is global

How MEA torpedoed the Bangladesh-India gas pipeline

Mani Shankar Aiyar is known for the many controversies sparked by his provocative comments and controversial ideas. As minister for petroleum and …

Bill will push PDS reform

Development economist JEAN DREZE, known for his work on issues such as hunger, famine, social and human development in India, child health and …